# Spinal or Intravenous Dexmedetomidine in Ambulatory Surgery

> **NCT02282319** · PHASE4 · COMPLETED · sponsor: **University Hospital, Antwerp** · enrollment: 150 (estimated)

## Conditions studied

- Surgery Ambulatory

## Interventions

- **DRUG:** spinal dexmedetomidine 0.5 mcg
- **OTHER:** spinal chloroprocaine 40 mg
- **DRUG:** IV dexmedetomidine 0.5 mcg/kg

## Key facts

- **NCT ID:** NCT02282319
- **Lead sponsor:** University Hospital, Antwerp
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282319, "Spinal or Intravenous Dexmedetomidine in Ambulatory Surgery". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02282319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*